-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 VsGlXipxcfThY7LsWDAxxZH5Welyhxe594hGP8ybVQBaRo44cBJvieY+rWOj/yQt
 0lWwg8uYuK9ue63HSzgU6g==

<SEC-DOCUMENT>0001157523-10-001506.txt : 20100311
<SEC-HEADER>0001157523-10-001506.hdr.sgml : 20100311
<ACCEPTANCE-DATETIME>20100311131219
ACCESSION NUMBER:		0001157523-10-001506
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20100305
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20100311
DATE AS OF CHANGE:		20100311

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ULTRALIFE CORP
		CENTRAL INDEX KEY:			0000875657
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		IRS NUMBER:				161387013
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20852
		FILM NUMBER:		10673273

	BUSINESS ADDRESS:	
		STREET 1:		2000 TECHNOLOGY PARKWAY
		CITY:			NEWARK
		STATE:			NY
		ZIP:			14513
		BUSINESS PHONE:		3153327100

	MAIL ADDRESS:	
		STREET 1:		2000 TECHNOLOGY PARKWAY
		CITY:			NEWARK
		STATE:			NY
		ZIP:			14513

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ULTRALIFE BATTERIES INC
		DATE OF NAME CHANGE:	19940224
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a6210256.htm
<DESCRIPTION>ULTRALIFE CORP. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2010 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <hr style="height: 3.0 pt; color: #000000; text-align: center; width: 100%">
    <hr style="height: 1.0 pt; color: #000000; text-align: center; width: 100%">


    <p style="text-align: center">
      <br>
      <font style="font-size: 12pt; font-family: Times New Roman"><b>United
      States</b></font><b><font style="font-size: 12pt; font-family: Times New Roman"><br style="font-family: Times New Roman; font-size: 12pt"></font><font style="font-size: 12pt; font-family: Times New Roman">Securities
      and Exchange Commission</font></b><br><font style="font-size: 12pt; font-family: Times New Roman"><b>Washington,
      D.C. 20549</b></font><br><br><br><font style="font-size: 18pt; font-family: Times New Roman"><b>FORM
      8-K</b></font><br><br><br><font style="font-size: 12pt; font-family: Times New Roman"><b>Current
      Report Pursuant to</b></font><br><font style="font-size: 12pt; font-family: Times New Roman"><b>Section
      13 or 15(d) of the Securities Exchange Act of 1934</b></font><br><br><br><font style="font-size: 12pt; font-family: Times New Roman"><b>March
      5, 2010</b></font><br>(<font style="font-size: 10pt">Date of Report)</font><br><br><br><font style="font-size: 18pt; font-family: Times New Roman"><b>ULTRALIFE
      CORPORATION</b></font><br><font style="font-size: 10pt; font-family: Times New Roman">(Exact
      name of registrant as specified in its charter)</font><br><br><br>
    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman; width: 100%">
      <tr>
        <td valign="top" style="text-align: center; padding-left: 0.0px; width: 33%">
          <p style="font-size: 10pt; margin-top: 0px; margin-bottom: 0px; font-family: Times New Roman">
            <b>Delaware</b>
          </p>
        </td>
        <td valign="bottom" style="white-space: nowrap; text-align: center; padding-left: 0.0px; padding-right: 0.0px; width: 34%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>000-20852</b>
          </p>
        </td>
        <td valign="bottom" style="white-space: nowrap; text-align: center; padding-left: 0.0px; padding-right: 0.0px; width: 33%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>16-1387013</b>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: center; padding-left: 0.0px; width: 33%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            (State of incorporation)
          </p>
        </td>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px; width: 34%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            (Commission File Number)
          </p>
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px; width: 33%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            (IRS Employer Identification No.)
          </p>
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>
      <br>

    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman; width: 100%">
      <tr>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px; width: 70%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>2000 Technology Parkway, Newark, New York</b>
          </p>
        </td>
        <td valign="top" style="white-space: nowrap; text-align: center; padding-left: 0.0px; padding-right: 0.0px; width: 30%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>14513</b>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px; width: 70%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <font style="font-family: Times New Roman; font-size: 10pt">(Address
            of principal executive offices)</font>
          </p>
        </td>
        <td valign="top" style="text-align: center; padding-left: 0.0px; width: 30%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            (Zip Code)
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">
      <br>
      <font style="font-family: Times New Roman; font-size: 10pt"><b>(315)
      332-7100</b></font><br>(Registrant&#8217;s telephone number, including area
      code)<br><br>
    </p>
    <hr style="color: #000000; text-align: center; height: 1.0 pt; width: 100%">


    <p style="text-align: center">
      <br>

    </p>
    <p style="text-align: left">
      <font style="font-family: Times New Roman; font-size: 10pt">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions </font>(see General Instruction A.2. below):
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
    <hr style="color: #000000; text-align: center; height: 1.0 pt; width: 100%">
    <hr style="color: #000000; text-align: center; height: 3.0 pt; width: 100%">


    <p>

    </p>
    <div style="margin-right: 0pt; margin-bottom: 10pt; margin-left: 0pt; text-indent: 0pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p>
      <b>Item 5.02&#160;&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of
      Directors; Appointment of Certain Officers; Compensatory Arrangements of
      Certain Officers.</b>
    </p>
    <p>

    </p>
    <p>
      On March 5, 2010, the Board of Directors (the &#8220;Board&#8221;) of Ultralife
      Corporation (the &#8220;Company&#8221;), on the recommendation of the Board&#8217;s
      Governance Committee, elected Thomas L. Saeli to the Board.&#160;&#160;Mr. Saeli
      will stand for re-election to the Board with the Company&#8217;s other
      director nominees at the Company&#8217;s annual meeting of shareholders on
      June 8, 2010.&#160;&#160;The Board expects to appoint Mr. Saeli to the Board&#8217;s
      Audit and Finance Committee and Strategy and Corporate Development
      Committee.
    </p>
    <p>

    </p>
    <p>
      The Board has determined that Mr. Saeli is an independent director under
      NASDAQ governance standards.&#160;&#160;There was no arrangement or understanding
      between Mr. Saeli and any other persons pursuant to which Mr. Saeli was
      selected as a director.&#160;&#160;As of the date of this Current Report on Form
      8-K, neither Mr. Saeli nor any of his immediate family members is a
      party, either directly or indirectly, to any transactions that would be
      required to be disclosed pursuant to Item 404(a) of Regulation S-K.
    </p>
    <p>

    </p>
    <p>
      Mr. Saeli will be entitled to the same compensation as the other
      non-employee directors who serve on the Board, as previously described
      in the Company&#8217;s filings with the Securities and Exchange Commission.
    </p>
    <p>

    </p>
    <p>
      A copy of the press release announcing Mr. Saeli&#8217;s election to the Board
      is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
    </p>
    <p>

    </p>
    <p style="white-space: nowrap">
      <b>Item 9.01&#160;&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</b>
    </p>
    <p style="white-space: nowrap; margin-left: 30.0px">
      <i>(d)&#160;&#160;Exhibits.</i>
    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman; width: 100%">
      <tr>
        <td valign="top" style="text-align: left; padding-left: 0.0px; padding-bottom: 2.0px; width: 7%">
          &#160;
        </td>
        <td valign="top" style="text-align: center; padding-left: 0.0px; border-bottom: solid black 1.0pt; width: 13%">
          Exhibit No.
        </td>
        <td valign="top" style="text-align: center; padding-left: 0.0px; border-bottom: solid black 1.0pt; width: 45%">
          Description
        </td>
        <td style="border-bottom: solid black 1.0pt; width: 35%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 7%">

        </td>
        <td valign="top" style="white-space: nowrap; text-align: center; padding-left: 0.0px; padding-right: 0.0px; width: 13%">
          99.1
        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 45%">
          Press Release, dated March 11, 2010.
        </td>
        <td style="width: 35%">

        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="margin-right: 0pt; margin-bottom: 10pt; margin-left: 0pt; text-indent: 0pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 10pt"><b>SIGNATURES</b></font>
    </p>
    <p style="text-indent: 30.0px">
      <font style="font-family: Times New Roman; font-size: 10pt">Pursuant to
      the requirements of the Securities Exchange Act of 1934, the Registrant
      has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</font>
    </p>
    <p style="text-indent: 30.0px">

    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman; width: 100%">
      <tr>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 5%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Date:
          </p>
        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 45%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            March 11, 2010
          </p>
        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 50%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>ULTRALIFE CORPORATION</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="width: 50%">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: left; padding-left: 0.0px; padding-bottom: 2.0px; width: 5%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; padding-bottom: 2.0px; width: 45%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; border-bottom: solid black 1.0pt; width: 50%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            /s/ Philip A. Fain
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 50%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Philip A. Fain
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 50%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Chief Financial Officer &amp; Treasurer
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a6210256ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2010 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 8pt">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>Ultralife
      Corporation Names Thomas L. Saeli to Board of Directors</b></font>
    </p>
    <p>
      NEWARK, N.Y.--(BUSINESS WIRE)--March 11, 2010--Ultralife Corporation
      (NASDAQ: ULBI) announced that Thomas L. Saeli has joined its board of
      directors, effective March 5. Mr. Saeli, 53, brings 28 years&#8217; experience
      in manufacturing, corporate development and finance.
    </p>
    <p>
      Presently, Mr. Saeli is a consultant advising international corporate
      clients on matters involving business development strategies,
      consolidations, acquisitions and operations. Previously, from March 2006
      until April 2009, he was chief executive officer of Noble International,
      Ltd., where he was also a member of Noble&#8217;s board of directors since
      2002. Prior to joining Noble, from 1998 Mr. Saeli served as vice
      president of corporate development for Lear Corporation where he also
      served as vice president of mergers &amp; acquisitions. Between 1989 and
      1998 Mr. Saeli was a partner with Oxford Investment Group, a
      Michigan-based merchant banking firm, where he served in various senior
      operating roles of portfolio companies. From 1983 to 1988, Saeli served
      in several corporate finance positions with Pepsico, Inc. He earned a BA
      in Economics from Hamilton College and an MBA in Finance and Accounting
      from Columbia University Graduate School of Business.
    </p>
    <p>
      John D. Kavazanjian, Ultralife&#8217;s president and chief executive officer,
      said, &#8220;Tom&#8217;s diverse background in international finance, business
      strategy and corporate development brings us a wealth of knowledge and
      experience. On behalf of the board of directors, we welcome Tom to
      Ultralife and look forward to having the benefit of his perspective and
      judgment in guiding our growth plans.&#8221;
    </p>
    <p>
      <b>About Ultralife Corporation</b>
    </p>
    <p>
      Ultralife Corporation, which began as a battery company, serves its
      markets with products and services ranging from portable and standby
      power solutions to communications and electronics systems. Through its
      engineering and collaborative approach to problem solving, Ultralife
      serves government, defense and commercial customers across the globe.
    </p>
    <p>
      Ultralife&#8217;s family of brands includes: Ultralife Batteries, Stationary
      Power Services, RPS Power Systems, ABLE, McDowell Research, RedBlack
      Communications and AMTI. Ultralife&#8217;s operations are in North America,
      Europe and Asia. For more information, visit <u>www.ultralifecorp.com</u>.
    </p>
    <p>
      This press release may contain forward-looking statements based on
      current expectations that involve a number of risks and uncertainties.
      The potential risks and uncertainties that could cause actual results to
      differ materially include: worsening global economic conditions,
      increased competitive environment and pricing pressures, and the
      possibility of intangible asset impairment charges that may be taken
      should management decide to retire one or more of the brands of acquired
      companies. The Company cautions investors not to place undue reliance on
      forward-looking statements, which reflect the Company&#8217;s analysis only as
      of today&#8217;s date. The Company undertakes no obligation to publicly update
      forward-looking statements to reflect subsequent events or
      circumstances. Further information on these factors and other factors
      that could affect Ultralife's financial results is included in
      Ultralife's Securities and Exchange Commission (SEC) filings, including
      the latest Annual Report on Form 10-K.
    </p>
    <p>
      CONTACT:<br>Company Contact:<br><u>Ultralife Corporation</u><br><b>Julius
      Cirin, </b>315-332-7100<br><u>jcirin@ultralifecorp.com</u><br>or<br>Investor
      Relations Contact:<br><u>Lippert/Heilshorn &amp; Associates, Inc.</u><br><b>Jody
      Burfening, </b>212-838-3777<br><u>jburfening@lhai.com</u>
    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
